Glibenclamide preserves postischaemic myocardial function in the isolated, erythrocyte perfused, working rat heart model. This study addresses the possible involvement of K ATP channels in this beneficial action of glibenclamide. We hypothesized that if glibenclamide improved postischaemic cardiac function by blocking of K ATP channels, opening of these K ATP channels should result in the opposite, namely detrimental effects on postischaemic heart function. Postischaemic functional loss and coronary blood flow were recorded during treatment with glibenclamide (4 mmol.l ª1 ; nΩ5), the K ATP channel openers pinacidil (1 mmol.l ª1 ; nΩ5) and diazoxide (30 mmol.l ª1 ; nΩ5), the combination of glibenclamide with pinacidil (nΩ5) and glibenclamide with diazoxide (nΩ5), and vehicle (nΩ8). Both pinacidil and diazoxide significantly increased coronary blood flow 2-3 times, which was abolished by glibenclamide pre-and postischaemically. This confirms that under both flow conditions glibenclamide significantly blocks K ATP channels in the coronary vasculature. The 12 min. global ischaemic incident resulted in a cardiac functional loss of 22.2∫2.9% during vehicle.